Search by Drug Name or NDC
NDC 23155-0240-41 Metoclopramide 5 mg/mL Details
Metoclopramide 5 mg/mL
Metoclopramide is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is METOCLOPRAMIDE HYDROCHLORIDE.
MedlinePlus Drug Summary
Metoclopramide injection is used to relieve symptoms caused by slow stomach emptying in people who have diabetes. These symptoms include nausea, vomiting, heartburn, loss of appetite, and feeling of fullness that lasts long after meals. Metoclopramide injection is also used to prevent nausea and vomiting caused by chemotherapy or that may occur after surgery. Metoclopramide injection is also sometimes used to empty the intestines during certain medical procedures. Metoclopramide injection is in a class of medications called prokinetic agents. It works by speeding the movement of food through the stomach and intestines.
Related Packages: 23155-0240-41Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Metoclopramide Injection
Product Information
| NDC | 23155-0240 |
|---|---|
| Product ID | 23155-240_a9c0f2bb-0052-4edc-a04d-1c4f599118bb |
| Associated GPIs | 52300020102005 |
| GCN Sequence Number | 005229 |
| GCN Sequence Number Description | metoclopramide HCl VIAL 5 MG/ML INJECTION |
| HIC3 | J9A |
| HIC3 Description | INTESTINAL MOTILITY STIMULANTS |
| GCN | 20510 |
| HICL Sequence Number | 002148 |
| HICL Sequence Number Description | METOCLOPRAMIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Metoclopramide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metoclopramide Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204756 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0240-41 (23155024041)
| NDC Package Code | 23155-240-41 |
|---|---|
| Billing NDC | 23155024041 |
| Package | 25 VIAL in 1 CARTON (23155-240-41) / 2 mL in 1 VIAL (23155-240-31) |
| Marketing Start Date | 2014-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |